Physician profile
Dusty Lambert-Wright
NPI 1073151007
$1,761.54
in general payments reported to CMS, 2019-2025
18 companies · $81.36 in 2025
The $81.36 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $1,162 · 2023: $199 · 2024: $111 · 2025: $81.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $676.60 | 2021-2025 | |
| Lilly USA, LLC | $233.94 | 2022 | |
| Novo Nordisk INC | $180.52 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $133.13 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.91 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $77.65 | 2022 | |
| Sanofi-Aventis U.S. LLC | $70.31 | 2022 | |
| Neurocrine Biosciences, INC. | $57.26 | 2022 | |
| Pfizer INC. | $36.59 | 2024 | |
| Paratek Pharmaceuticals, INC. | $33.46 | 2022 | |
| Hologic Sales and Service, LLC | $22.68 | 2025 | Aptima |
| Boston Scientific Corporation | $22.63 | 2025 | Dreamtome Rx 49 |
| Janssen Pharmaceuticals, INC | $21.44 | 2022 | |
| Xeris Pharmaceuticals, INC. | $17.68 | 2022 | |
| Supernus Pharmaceuticals, INC. | $16.05 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $15.93 | 2022 | |
| Acadia Pharmaceuticals INC | $15.24 | 2021 | |
| Genzyme Corporation | $14.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dusty Lambert-Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.